Yuan, Z.-G., Ren, D., Zhou, D.-H., Zhang, X.-X.
, Petersen, E., Li, X.-Z., Zhou, Y., Yang, G.-L. & Zhu, X.-Q. (2013).
Evaluation of protective effect of pVAX-TgMIC13 plasmid against acute and chronic Toxoplasma gondii infection in a murine model.
Vaccine,
31(31), 3135-9.
https://doi.org/10.1016/j.vaccine.2013.05.040
Yan, H.-K., Yuan, Z.-G.
, Petersen, E., Zhang, X.-X., Zhou, D.-H., Liu, Q., He, Y., Lin, R.-Q., Xu, M.-J., Chen, X.-L., Zhong, X.-L. & Zhu, X.-Q. (2011).
Toxoplasma gondii: protective immunity against experimental toxoplasmosis induced by a DNA vaccine encoding the perforin-like protein 1.
Experimental Parasitology,
128(1), 38-43.
https://doi.org/10.1016/j.exppara.2011.02.005
Yan, H.-K., Yuan, Z.-G., Song, H.-Q.
, Petersen, E., Zhou, Y., Ren, D., Zhou, D.-H., Li, H.-X., Lin, R.-Q., Yang, G.-L. & Zhu, X.-Q. (2012).
Vaccination with a DNA vaccine coding for perforin-like protein 1 and MIC6 induces significant protective immunity against Toxoplasma gondii.
Clinical and Vaccine Immunology (Online),
19(5), 684-9.
https://doi.org/10.1128/CVI.05578-11
Yan, X., Ols, S., Arcoverde Cerveira, R., Lenart, K., Hellgren, F., Ye, K., Cagigi, A., Buggert, M., Nimmerjahn, F.
, Falkesgaard Højen, J., Parera, D., Pessara, U., Fischer, S. & Loré, K. (2023).
Cell targeting and immunostimulatory properties of a novel Fcγ-receptor-independent agonistic anti-CD40 antibody in rhesus macaques.
Cellular and Molecular Life Sciences,
80(7), Artikel 189.
https://doi.org/10.1007/s00018-023-04828-2
Wyles, D., Wedemeyer, H., Ben-Ari, Z., Gane, E. J.
, Hansen, J. B., Jacobson, I. M.
, Laursen, A. L., Luetkemeyer, A., Nahass, R., Pianko, S., Zeuzem, S., Jumes, P., Huang, H.-C., Butterton, J., Robertson, M., Wahl, J., Barr, E., Joeng, H.-K., Martin, E. ... C-CREST Part C and C-SURGE Investigators (2017).
Grazoprevir, Ruzasvir, and Uprifosbuvir for HCV After NS5A Treatment Failure.
Hepatology.
https://doi.org/10.1002/hep.29358
Wu, G., Swanson, M., Talla, A., Graham, D., Strizki, J., Gorman, D., Barnard, R. J., Blair, W.
, Søgaard, O. S., Tolstrup, M., Østergaard, L., Rasmussen, T. A., Sekaly, R.-P., Archin, N. M., Margolis, D. M., Hazuda, D. J. & Howell, B. J. (2017).
HDAC inhibition induces HIV-1 protein and enables immune-based clearance following latency reversal.
JCI Insight,
2(16), Artikel e92901.
https://doi.org/10.1172/jci.insight.92901
Worm, S. W., Friis-Møller, N., Bruyand, M., D'Arminio Monforte, A., Rickenbach, M., Reiss, P., El-Sadr, W., Phillips, A., Lundgren, J., Sabin, C. & D:A:D study group (Lars Østergaard, member) (2010).
High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome.
AIDS,
24(3), 427-35.
https://doi.org/10.1097/QAD.0b013e328334344e
Woolley, I. J., Larsen, M., Jones, S., Gahan, M. E., Jasenko, I.
, Johnsen, S. P., Wesselingh, S., Fuller, A.
& Østergaard, L. (2004).
Chlamydia pneumoniae in HIV infected patients and controls assessed by a novel blood Interferon-gamma assay, serology, and PCR.
Clinical Microbiology and Infecttion,
10(19), 820-5.
Woolley, I. J., Li, X., Jacobson, L. P., Palella, F. J.
& Østergaard, L. (2007).
Macrolide use and the risk of vascular disease in HIV-infected men in the Multicenter AIDS Cohort Study. Sexual Health,
4(2), 111-9.
Woolley, I. J., Larsen, M., Jones, S., Gahan, M. E., Jasenko, I., Johnsen, S. P., Wesselingh, S., Fuller, A.
& Østergaard, L. J. (2004).
Chlamydia pneumoniae in HIV-infected patients and controls assessed by a novel whole blood interferon-gamma assay, serology and PCR.
Clinical Microbiology and Infection,
10(9), 820-5.
https://doi.org/10.1111/j.1198-743X.2004.00952.x